期刊文献+

1254例维持性血液透析患者长期生存分析 被引量:70

Long-term outcome of 1254 patients with maintenance hemodialysis
下载PDF
导出
摘要 目的:了解维持性血液透析(MHD)患者的临床流行病学资料、长期生存率及其影响因素。方法:回顾性分析1974-01-01至2004-12-31在我院确诊为终末期慢性肾脏疾病(ESRD)行血液透析(hemodialysis,HD)治疗超过3个月的MHD患者的性别、年龄、原发病因分布,治疗的转归,长期生存率及其影响因素。结果:①男性占69.70%,女性占30.30%,男/女为1/0.44,开始HD治疗时平均年龄11~88(42.33±13.64)岁,中位年龄40岁,透析时间3月~22.5年。②已明确原发病因的患者中,原发性肾小球疾病700例占68.29%,继发性肾小球疾病193例(19.12%),小管间质性疾病61例(5.95%),先天遗传性疾病58例(5.66%),其他原因者13例(0.98%)。IgA肾病是导致ESRD最常见的原发性肾小球疾病(占53.57%)。继发性肾小球疾病<50岁组前三位病因分别为:狼疮性肾炎(26.31%)、高血压肾损害17例(22.36%)和过敏紫癜性肾炎12例(15.79%);≥50岁组前三位分别为:糖尿病肾病53例(44.16%)、高血压肾损害48例(40.00%)和尿酸性肾病7例(5.83%)。③MHD患者中484例(38.60%)行肾移植,449例(35.80%)转院治疗,改腹膜透析32例(2.55%),目前仍在院HD治疗者153例占(12.20%),死亡136例(占10.85%);④MHD患者的1年存活率为(92.42%),5年存活率为(72.57%),10年存活率为(60.71%),15年存活率为51. Objective: To analyze the clinical data of patients with maintenance hemodialysis(MHD) in a single blood purification center in China. Methodology:We retrospectively studied the clinical records of 1254 patients with MHD betwee n January 1974 and December 2004. The data on the demographic and epidemiologic aspects of these patients were examined. The age at the start of HD, causes of e nd-stage renal disease (ESRD), period of start HD and dialysis frequency, the su rvival rates and risk factors were analyzed. Results:①The mean age at start of HD was 11 to 88,median 40(42.3±13.6) years old. 6 9.7% of patients in this group were males, 30.30% were females, and the ratio of male to female was 1 to 0.44.② Primary glomerular disease was the most freq uent cause of ESRD, and accounted for 68.3% in our patients, secondary glomerula r disease for 19.1%. In the younger patient (<50y at the start of HD) group, pr imary glomerulonephritis accounted for 80.4% and secondary glomerular disease fo r 9.68%, while in the older group (≥50y at the start of HD), primary glomerulo nephritis only accounted for 28.8% and secondary glomerular disease for 50.0%. IgA nephropathy was the most common primary glomerulonephtitis in those patient s, and accounted for 53.6%. Lupus nephritis (26.3%) was the most common second ary glomerular disease in the younger patients, and diabetic nephropathy (44.2% ) in the older patients.③ Among the 1 254 MHD patients, 38.6% of them recei ved renal transplantation, 35.8% transferred to other hospitals for hemodialysis , 10.9% of them died and the others (12.2%) were still hospitalized in our un its.④ The 1 year, 5 year, 10 year and 15 year survival rate of patients with MHD was 92.4%,72.6%, 60.7%, and 51.4% respectively. Cox proportional hazard analyses showed that risk factors were older age, diabetes, hypertension, insuf ficiency of HD and early period start of HD. Conclusion:In our dialysis center, the majority of the ESRD patients was younger males, wit h primary glomerular disease as the most common cause. In mortality of patients with MHD was lower in 10.9%. The older age, original disease as diabetes and hy pertension, insufficiency of HD and early period start of HD were the risk facto rs.
出处 《肾脏病与透析肾移植杂志》 CAS CSCD 2005年第2期136-141,共6页 Chinese Journal of Nephrology,Dialysis & Transplantation
  • 相关文献

参考文献11

二级参考文献29

  • 1龚德华,季大玺,谢红浪.高通量透析器复用的研究[J].医学研究生学报,2000,13(5):307-310. 被引量:26
  • 2[1]Hughes RD,Williams R.Use of bioa rtificial and artificial liver support d evices.Semin Liver Dis,1996,16(4):435
  • 3[2]Ash SR,Blake DE,Carr DJ et al.Push-p ull sorbent based pheresis for treatment of acute hepatic failure:the biologic-d etoxifier/plasma filter system.ASAIO J,1 998,44:129
  • 4[3]Kramer L,Gendo A,Madl C et al.Biocom patibility of a cuprophane charcoal-base d detoxification device in cirrhotic pat ients with hepatic encephalopathy.Am J K idney Dis,2000,36:1193
  • 5[4]Stange J,Ramlow W,Mitzner S et al.Di alysis against a recycled albumin soluti on enables the removal of albumin-bound toxins.Artif Organs,1993,17:809
  • 6[5]Mitzner S,Stange J,Klammt S et al .Albumin dialysis using the molecular a dsorbent recirculating system.Curr Opin Nephrol Hypertens,2001,10:777
  • 7[6]Loock J,Stange J,Mitzner S et al.Inf luence of albumin dialysis(MARS) on the neuronal network activity.Z Gastroentero l,2001,39(Suppl S2):28
  • 8[7]Novelli G,Rossi M,Pretagostini R et a l. Use of MARS in the treatment of acut e liver failure:preliminary monocentric experience.Transplant Proc,2001,33:1942
  • 9[8]Siewert-Delle A,Henriksson BA,Bckman L.Albumin dialysis with the MARS(molecul ar adsorbent recirculating system)for a patient with acute liver failure due to paracetamol intoxication:a case report(a bstract).Z Gastroenterol,2001,39(Suppl S 2):48
  • 10[9]kreymann B,Seige M,Schweigart U et al .Albumin dialysis:effective removal of copper in a patient with fulminant Wilso n disease and successful bridging to liv er transplantation:a new possibility for the elimination of protein-bound toxins .J Hepatol,1999,31:1080

共引文献88

同被引文献649

引证文献70

二级引证文献593

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部